Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PCNSL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04931368
What this trial is testing

OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Klinikum Stuttgart 331
Not applicableUnknownNCT05347511
What this trial is testing

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

Who this might be right for
Rare Disease With Poor Outcome
Central Hospital, Nancy, France 94
Testing effectiveness (Phase 2)Looking for participantsNCT06343311
What this trial is testing

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
B-Cell Non-Hodgkin's Lymphoma (NHL)Lymphoma, Non-HodgkinsLymphomas Non-Hodgkin's B-Cell+12 more
Estrella Biopharma, Inc. 21
Early research (Phase 1)Study completedNCT00006340
What this trial is testing

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Who this might be right for
LeukemiaLymphomaPrecancerous Condition+1 more
Boston Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03220646
What this trial is testing

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Who this might be right for
Brain Tumor
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT02952508
What this trial is testing

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

Who this might be right for
Waldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic Leukemia+6 more
Cellectar Biosciences, Inc. 120
Testing effectiveness (Phase 2)UnknownNCT01985451
What this trial is testing

Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）

Who this might be right for
Central Nervous System Tumors
Rongjie Tao 15
Testing effectiveness (Phase 2)Looking for participantsNCT07062627
What this trial is testing

Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

Who this might be right for
Primary CNS Lymphoma (PCNSL)Diffuse Large B Cell Lymphoma (DLBCL)
Hyungwoo Cho 12
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Testing effectiveness (Phase 2)Ended earlyNCT00517699
What this trial is testing

MabThera (Rituximab) in Primary Central Nervous System Lymphoma.

Who this might be right for
Lymphoma
Hoffmann-La Roche 5
Testing effectiveness (Phase 2)Ended earlyNCT01235793
What this trial is testing

The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma

Who this might be right for
B-Cell Lymphoma Originating in the CNS
Cedars-Sinai Medical Center 11
Early research (Phase 1)Study completedNCT00077155
What this trial is testing

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more
National Cancer Institute (NCI) 45
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT00103038
What this trial is testing

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Who this might be right for
Central Nervous System LymphomaMalignant GliomaMetastatic Malignant Neoplasm in the Brain
OHSU Knight Cancer Institute 155
Not applicableStudy completedNCT00445952
What this trial is testing

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 304
Testing effectiveness (Phase 2)UnknownNCT00863460
What this trial is testing

Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

Who this might be right for
Primary Central Nervous System Lymphoma
Institut Curie 140
Not applicableNot Yet RecruitingNCT07764601
What this trial is testing

R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System LymphomaDiffuse Large B-Cell Lymphoma
WEI XU 58
Testing effectiveness (Phase 2)Study completedNCT00002676
What this trial is testing

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)UnknownNCT00503594
What this trial is testing

Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine

Who this might be right for
Lymphoma
Assistance Publique - Hôpitaux de Paris 92
Early research (Phase 1)Study completedNCT03703167
What this trial is testing

Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
Memorial Sloan Kettering Cancer Center 25
Next Page